He completed fellowship and residency training in hematology/oncology at Vanderbilt University Medical Center, after attending medical school at Vanderbilt and earning a PhD degree in biochemistry. His research aims to understand mechanisms of resistance to targeted therapies in cancer and to identify potential therapies to overcome that resistance. In particular, he is focused on studying resistance to lapatinib in breast cancer.